Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

Sponsor
University of California, San Diego (Other)
Overall Status
Completed
CT.gov ID
NCT03413696
Collaborator
(none)
150
1
27.7
5.4

Study Details

Study Description

Brief Summary

A clinical observational study for patients with HIV co-infected with hepatitis C that investigates the levels of their health literacy, hepatitis C and HIV knowledge. Participants will complete a one-time assessment of these studied domains and categorized in three groups defined by their hepatitis C treatment referral status: not-referred, referred-attended, referred and no-show.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The main purpose of this research study is to investigate the prevalence of inadequate health literacy and hepatitis C knowledge and their determinants among people living with HIV/AIDS co-infected with hepatitis C. The observation will determine if health literacy and/or hepatitis C knowledge are predictors of patient willingness and intention to be treated for HCV in the overall cohort and stratified according to study groups as noted above.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    150 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Effects of Health Literacy and Hepatitis C Knowledge on Hepatitis C Treatment Willingness in HIV-coinfected Patients, According to Hepatitis C Treatment Referral Status
    Actual Study Start Date :
    Sep 8, 2017
    Actual Primary Completion Date :
    Dec 31, 2019
    Actual Study Completion Date :
    Dec 31, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Not referred for HCV therapy

    Referred for HCV therapy,did not show up

    Referred,attended HCV therapy evaluation

    Outcome Measures

    Primary Outcome Measures

    1. Inadequate health literacy (s-TOFHLA inventory) [Baseline before HCV treatment consideration]

      The primary outcome will measure the point prevalence of inadequate health literacy among persons with HIV/AIDS with active hepatitis C infection.

    Secondary Outcome Measures

    1. Hepatitis C knowledge (using the modified Treolar's scale) [Baseline before HCV treatment consideration]

    Other Outcome Measures

    1. Determinants of inadequate health literacy and HCV knowledge [Baseline before HCV treatment consideration]

      To ascertain determinants of inadequate health literacy and HCV knowledge among PLWH coinfected with HCV in the overall study group and stratified according to group membership: (1) not referred for HCV therapy, (2) those referred but no show, and (3) those referred and attended HCV therapy.

    2. Predictors of patient willingness to HCV treatment [Baseline before HCV treatment consideration]

      To ascertain predictors of patient willingness and intention to be treated for HCV with particular attention to the independent effect of health literacy and HCV knowledge in the overall cohort and stratified according to study groups as noted above.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Any adult (≥ 18 years) HIV-infected patient attending the UCSD Owen Clinic

    • Regardless of ethnic background

    • English or Spanish speaking

    • With active HCV infection defined as having a detectable HCV viral load with or without a positive HCV antibody

    Exclusion Criteria:
    • Neurocognitive impairment precluding participation

    • Physical illness precluding participation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Owen Clinic - University of California, San Diego San Diego California United States 92103-8186

    Sponsors and Collaborators

    • University of California, San Diego

    Investigators

    • Principal Investigator: Edward Cachay, MD, MAS, University of California, San Diego

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Edward Cachay, MD, MAS, Associate Professor of Clinical Medicine, University of California, San Diego
    ClinicalTrials.gov Identifier:
    NCT03413696
    Other Study ID Numbers:
    • 20170991
    • 170218
    First Posted:
    Jan 29, 2018
    Last Update Posted:
    Sep 5, 2021
    Last Verified:
    Sep 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Edward Cachay, MD, MAS, Associate Professor of Clinical Medicine, University of California, San Diego
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 5, 2021